Design Therapeutics, Inc.
Design Therapeutics, Inc.（DSGN）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dsgn · 股价预测 · 7 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 7 位华尔街分析师
Buy
7 位分析师
共识
评级分布
12 个月目标价
High
$21.00
Consensus
$20.50
+96.0% upside
Low
$20.00
Median: $20.5 · Last Close: $10.46
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$20.50
96.0% upside
High Target
$21
100.8%
Low Target
$20
91.2%
Current Price
$10.46
as of today
Based on analyst price targets, the DSGN stock price prediction for the next 12 months ranges from $20 to $21. The consensus DSGN price forecast of $20.50 implies 96.0% upside from the current price of $10.46.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $9.94 | ↓ 5.00% |
1-day model range: $9.8–$10.08. Peak: $10.08 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $19 | +80.0% |
| 2028 | $27 | +159.3% |
| 2029 | $34 | +222.1% |
| 2030 | $38 | +265.0% |
| 2031 | — | +291.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DSGN · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-03-10 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-12-03 | Leerink Partners | Upgrade ↑ | Market Perform→Outperform |
| 2025-11-20 | RBC Capital | Upgrade ↑ | Sector Perform→Outperform |
| 2025-11-06 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-08-06 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-05-07 | Piper Sandler | Upgrade ↑ | Neutral→Overweight |
| 2024-03-20 | Wedbush | Maintains | Neutral→Neutral |
| 2024-03-20 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2023-11-14 | RBC Capital | Maintains | Sector Perform→Sector Perform |
Wall Street analysts have recently issued updated ratings on Design Therapeutics, Inc. (DSGN) stock. Of the recent 28 rating actions, 4 were upgrades and 3 were downgrades. 7 analysts currently cover DSGN.
分析师推荐趋势
DSGN analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$117M
↑ 1296.8% YoY
Revenue Next Year
$205M
↑ 74.5% YoY
EPS This Year
$-1.36
EPS Next Year
$-1.64
↑ 20.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast DSGN EPS of $-1.36 for the current fiscal year, based on estimates from 5 analysts. The DSGN revenue forecast is $117M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DSGN 股价预测由两类独立数据源支撑：来自 7 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DSGN 的共识目标价为 $20.50（+96.0% 上行空间），分析师共识为 Buy。
DSGN 的短期预测（明日）为 $9.94（-5.00%）。 DSGN 对 2027 年的股价预测均值为 $19。 DSGN 对 2030 年的预测区间为 $32–$44。
Design Therapeutics, Inc. 在 NASDAQ 上市，代码 DSGN。DSGN 在 2027 年的整体展望偏积极，在覆盖分析师中约 57% 对应 Buy 共识。
常见问题
DSGN 预测 · 8 个问题根据 7 位华尔街分析师，DSGN 的 12 个月平均目标价为 $20.50，最高 $21.00、最低 $20.00。若有图表，中位目标价可在上方查看。相对当前价 $10.46，隐含约 +96.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.